What smart money is saying about Citigroup
C
No fund has written a full thesis on Citigroup in our archive, but 24 fund letters report a position in it — most recently Hardman Johnston Global Equity in September 2026.
Get an email when a fund buys, sells or pitches it
Fund signal · last 12 months
20 lettersMore funds are buying than selling
+3
Net flow
4 buys · 1 new position · 80%1 sell
Moves described in fund letters in our archive. A sentence published word for word by several funds of one house in the same quarter counts once.
Position history
Between Q2 2025 and Q3 2026, 24 fund letters reported a position in Citigroup, with 4 buys (opened or added) and 2 sells (trimmed or exited).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 8 | 3 | 1 | 0 |
| Q2 2026 | 9 | 1 | 0 | 0 |
| Q4 2025 | 3 | 0 | 0 | 0 |
| Q3 2025 | 1 | 0 | 1 | 0 |
| Q2 2025 | 3 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 24 positions · 7 moves
- September 2026
“Citigroup Inc.”
Citigroup - September 2026
“• Traditional value opportunities such as Citigroup, Anglo American, Weyerhaeuser, Japan Post, Vivendi and Samsung Life, alongside several attractively valued domestic businesses around the world.”
Citigroup - September 2026
Listed in Brown Advisory Large-Cap Sustainable Value Strategy’s reported holdings.
Citigroup - September 2026
“The portfolio added several names in the financials sector, including NU Holdings, Citigroup and Wells Fargo.”
Citigroup - September 2026
“Portfolio Changes We continued to refine the portfolio around a number of high-conviction positions whilst maintaining our focus on businesses benefiting from long-term structural growth trends. The most extensive repositioning occurred in healthcare where we initiated new positions in DexCom and Boston Scientific, and reinstated Intuitive Surgical after its T score improved. These trades add exposure to high-quality medical technology businesses after periods of share-price weakness. DexCom provides exposure to the long- term adoption of continuous glucose monitoring, while Intuitive Surgical is a global leader in robotic-assisted surgery and Boston Scientific earnings look to be at an inflection point. We funded this by fully exiting Novo Nordisk and EssilorLuxottica. The portfolio added several names in the financials sector, including Citigroup and Wells Fargo.”
Citigroup - September 2026
“To fund these additions, we trimmed Dutch bank ING Groep following share-price strength, and we trimmed both U.S. bank Citigroup and Swiss bank UBS on valuation.”
Citigroup - New positionLiontrust GF Global Alpha FundJuly 2026
“Portfolio changes The portfolio added three names in the financials sector: NU Holdings, Citigroup and Wells Fargo.”
Citigroup - New positionLiontrust Global Alpha FundJuly 2026
“Portfolio changes The portfolio added three names in the financials sector: NU Holdings, Citigroup and Wells Fargo. Financials look set to benefit from the ‘stronger for longer’ theme”
Citigroup - June 2026
“It is also notable how diversified our return was for the quarter. Samsung was, of course, a home run and our best performer. But Elevance (health insurance company), Alphabet, Bank of New York Mellon (trust and custody bank) and Citigroup (money center bank) all returned between 22% and 33%.”
Citigroup - June 2026
“Through most of April, with yields still looking high and therefore offering value against our models, we were happy to pick up limited issuance of six-month paper from issuers that scored well on our credit and ESG criteria, such as Swedbank, United Overseas Bank and Nordea Bank, all at yields well over SONIA. As yields decreased, participation in these longer maturity instruments decreased, with the focus on three- month CDs from the likes of KBC, Citibank and Santander.”
Citigroup - June 2026
“Aramark (contract catering), Elevance (health insurance company), Alphabet and Citigroup (money center bank) all returned between 24% and 40%.”
Citigroup - June 2026
“The diverse source of our returns this quarter is notable. Samsung was, of course, a home run and our best performer. But Aramark (contract catering), Elevance (health insurance company), Alphabet and Citigroup (money center bank) all returned between 24% and 40%.”
Citigroup - HoldsGator Financial Partners Financials Sector Hedge FundsJune 2026
“The largest detractors were long positions in Fiserv and Carlyle and short positions in TD Bank, Citigroup, and KeyCorp.”
Citigroup - June 2026
“As yields decreased, participation in these longer maturity instruments decreased, with the focus on three-month CDs from the likes of Australia and New Zealand Banking KBC, Citibank and Santander.”
Citigroup “In financials, the strategy saw good performance from large banks, including Citigroup, on an increase in fees and a strong IPO pipeline coupled with a lack of exposure to financial exchanges, which faced new competition from non-financial institutions.”
Citigroup- June 2026
“Nevertheless, several of the Fund’s bank holdings performed well, including U.S.-based Citigroup, Switzerland-based UBS and Austria-based Erste Group.”
Citigroup - June 2026
Listed in Homestead Advisers Funds’s reported holdings.
Citigroup - December 2025
“Our overweight allocation to and strong stock selection within the Financials sector made it the largest contributor to relative performance for the quarter. Citigroup (+15.6%) has had a string of positive earnings releases this year, and 3Q’25 continued the trend.”
Citigroup - HoldsDavenportDecember 2025
“Fund Update Contributors: Several financial holdings were among the Fund’s best quarterly performers, led by Citigroup Inc. (C) at +16%.”
Citigroup - December 2025
“Strong stock selection within the Financials sector made it the largest contributor to relative performance for the quarter. Citigroup (+15.6%) has had a string of positive earnings releases this year, and 3Q’25 continued the trend.”
Citigroup - TrimmedPzena Focused ValueSeptember 2025
“During the quarter, we initiated a new position in PPG Industries, a leading coatings provider. PPG boasts enviable franchises across multiple coatings markets and has generated attractive returns on capital historically. Shares are currently trading at a discounted valuation due to concerns around tepid organic growth relative to peers. We see these concerns as overly discounted in the valuation and expect growth to improve over time as some key end markets recover from cyclical pressure. We also initiated a new position in medical device company Solventum, a recent spinoff from 3M. Concerns around operational challenges and margin pressure caused by the separation from 3M, in addition to high financial leverage, resulted in an attractive entry point. We expect the company to benefit from self-help opportunities going forward as an independent company and see a clean balance sheet after recently divesting a non-core asset at a premium valuation. We trimmed TE Connectivity, CVS Health, and Citigroup all on strength.”
Citigroup - June 2025
Listed in RS Large Cap Value Strategy’s reported holdings.
Citigroup - June 2025
“Source: FactSet. The top contributors and detractors are presented to illustrate examples of the portfolio’s investments and may not be representative of the portfolio’s current or future investments. The information in this article is based on data obtained from recognized services and sources and is believed to be reliable. Any opinions, projections or recommendations in this report are subject to change without notice and are not intended as individual investment advice. The securities highlighted, if any, were not intended as individual investment advice. The RS Concentrated All Cap Value Strategy primarily invests in a diversified portfolio of small-cap, mid-cap, and large-cap companies. Information relating to portfolio holdings is based on the representative account in the composite and may vary for other accounts in the strategy due to asset size, client guidelines, and other factors. The representative account is believed to most closely reflect the current portfolio management style. Advisory services offered by Victory Capital Management Inc. V17.083 // 2Q 2025 RS Concentrated All Cap Strategy COM Holding % Contribution to Return Holding % Contribution to Return Gates Industrial Corporation plc 0.88 Graphic Packaging Holding Company -0.70 Fluor Corporation 0.82 Littelfuse, Inc. -0.52 Citigroup Inc. 0.75 Sensata Technologies Holding PLC -0.52”
Citigroup - June 2025
“Top contributors: • Citigroup was a contributor during the quarter.”
Citigroup
Also mentioned · 2
These funds discuss Citigroup — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedSignia Small Micro Cap ValueDecember 2025
“On March 7th, 2025, GDOT named formed CEO and current Board Chair, Bill Jacobs, Interim CEO. On March 10th, 2025, GDOT announced that it had engaged Citigroup to initiate a review of strategic alternatives.”
Citigroup - MentionedBlackrockDecember 2025
“Citigroup CEO Jane Fraser: “AI tools are freeing up about 100,000 development hours per week.” ― Reuters, October 2025”
Citigroup
Read the letters behind these Citigroup positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger